Drug Master Files for: FLUTICASONE PROPIONATE
✉ Email this page to a colleague
FLUTICASONE PROPIONATE Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
15456 | A | II | 5/24/2001 | WAVELENGTH ENTERPRISES LTD | FLUTICASONE PROPIONATE |
15686 | I | II | 10/19/2001 | SCINOPHARM TAIWAN LTD | FLUTICASONE PROPIONATE |
15745 | A | II | 11/29/2001 | TEVA PHARMACEUTICAL INDUSTRIES LTD | FLUTICASONE PROPIONATE |
15774 | A | II | 12/19/2001 | CIPLA LTD | FLUTICASONE PROPIONATE USP |
16334 | A | II | 12/20/2002 | HOVIONE FARMACIENCIA SA | FLUTICASONE PROPIONATE |
16423 | A | II | 2/12/2003 | STERLING SPA | FLUTICASONE PROPIONATE |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information